451 related articles for article (PubMed ID: 10458169)
21. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY
Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445
[TBL] [Abstract][Full Text] [Related]
22. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.
Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX
Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221
[TBL] [Abstract][Full Text] [Related]
23. Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
Chen SN; Ho CL; Kuo YH; Ho JD
Retina; 2001; 21(5):460-3. PubMed ID: 11642374
[TBL] [Abstract][Full Text] [Related]
24. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
Inoue M; Shiraga F; Shirakata Y; Morizane Y; Kimura S; Hirakata A
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1663-9. PubMed ID: 25418034
[TBL] [Abstract][Full Text] [Related]
25. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy.
Cooper BA; Thomas MA
Am J Ophthalmol; 2000 Aug; 130(2):187-91. PubMed ID: 11004292
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Kung YH; Wu TT; Hong MC; Sheu SJ
J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
[TBL] [Abstract][Full Text] [Related]
27. Long-term visual outcomes for treatment of submacular haemorrhage secondary to polypoidal choroidal vasculopathy.
Kang HG; Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
Clin Exp Ophthalmol; 2018 Nov; 46(8):916-925. PubMed ID: 29652440
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcomes in eyes with polypoidal choroidal vasculopathy with poor baseline visual acuity.
Kim JH; Kim JW; Lee TG; Lew YJ
J Ocul Pharmacol Ther; 2015 May; 31(4):241-7. PubMed ID: 25786032
[TBL] [Abstract][Full Text] [Related]
29. Polypoidal choroidal vasculopathy exudation and hemorrhage: results of monthly ranibizumab therapy at one year.
Kokame GT; Yeung L; Teramoto K; Lai JC; Wee R
Ophthalmologica; 2014; 231(2):94-102. PubMed ID: 24135557
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic polypoidal choroidal vasculopathy in Japanese patients.
Uyama M; Matsubara T; Fukushima I; Matsunaga H; Iwashita K; Nagai Y; Takahashi K
Arch Ophthalmol; 1999 Aug; 117(8):1035-42. PubMed ID: 10448746
[TBL] [Abstract][Full Text] [Related]
31. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
Hillenkamp J; Surguch V; Framme C; Gabel VP; Sachs HG
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
[TBL] [Abstract][Full Text] [Related]
32. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
Chan WM; Liu DT; Lai TY; Li H; Tong JP; Lam DS
Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
[TBL] [Abstract][Full Text] [Related]
33. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
34. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
[TBL] [Abstract][Full Text] [Related]
35. Visual Recovery and Prognosis in the Treatment of Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy and Retinal Arterial Macroaneurysm: A Retrospective Study.
Wu J; Yan T; Zhang R; Feng C; Xu C; Xu T; Li Y; Wang S; He J
Int J Clin Pract; 2023; 2023():3880297. PubMed ID: 37342617
[TBL] [Abstract][Full Text] [Related]
36. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
[TBL] [Abstract][Full Text] [Related]
37. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
Zhao XY; Xia S; Luo MY; Wang EQ; Chen YX
Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
[TBL] [Abstract][Full Text] [Related]
38. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
Hesse L; Schmidt J; Kroll P
Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
[TBL] [Abstract][Full Text] [Related]
39. Visual prognosis of massive submacular hemorrhage in polypoidal choroidal vasculopathy with or without combination treatment.
Lin TC; Hwang DK; Lee FL; Chen SJ
J Chin Med Assoc; 2016 Mar; 79(3):159-65. PubMed ID: 26775600
[TBL] [Abstract][Full Text] [Related]
40. [Surgical management of sub-retinal haemorrhage secondary to polypoidal choroidal vasculopathy].
Schweitzer C; Bonnel S; Le Mer Y; Wolff B; Colin J; Sahel JA
J Fr Ophtalmol; 2011 Oct; 34(8):557.e1-7. PubMed ID: 21507515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
